The most significant risk is hypoglycemia, especially for patients also taking insulin or sulfonylureas
No phase 2 dose-finding trial
However, because this was not a randomized trial, we cannot say hormone therapy caused additional weight loss," she said
While compounded tirzepatide is not FDA-approved, our preferred pharmacy provider adheres to all relevant federal and state regulations and FDA guidelines.* Other medication treatment options: Ozempic (semaglutide): Ozempic comes in a once-weekly injectable format
Starting a tirzepatide journey often brings excitement mixed with curiosity
The right dose is personal and should be chosen with your provider based on how your weight has stabilized, how your body responds, and what fits into your daily life